Serelaxin To Lower Portal Pressure

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
Portal hypertension (an increase in blood pressure in the portal vein that carries the blood from the intestine and spleen to the liver) underlies most of the serious complications of liver cirrhosis. This randomised placebo controlled study in people with liver cirrhosis evaluates the acute effects serelaxin (RLX030) infusion on portal hypertension and liver blood flow.
Epistemonikos ID: 5b28eb41591dd3d0ee39941278eac98a19da048c
First added on: Nov 24, 2021